
Loading, please wait...

Loading, please wait...

Placenta previa (PP) and placenta accreta spectrum (PAS) are critical obstetric conditions. These conditions are often linked to severe maternal physical complications. However, managing antenatal anxiety and depression is equally vital for maternal well-being. A recent cross-sectional study highlights how these conditions significantly elevate psychological distress. This distress is particularly evident during the third trimester. Therefore, clinicians must recognize the deep emotional burden of a high-risk diagnosis. Additionally, the impact of these conditions extends far beyond physical health, affecting the overall quality of life.
The study evaluated 127 women to compare mental health outcomes between complicated and uncomplicated pregnancies. Researchers found that those in the PP/PAS group experienced significantly higher prenatal anxiety. This anxiety affected all measured domains of the Perinatal Anxiety Screening Scale. Moreover, this anxiety showed a moderate positive correlation with postpartum depressive symptoms. Consequently, women who exceed clinical cut-offs for anxiety during pregnancy often require proactive psychiatric support. They need this intervention to prevent worsening symptoms after delivery. In addition, early counseling can stabilize the mother's emotional state before the high-stress period of childbirth.
Furthermore, early identification of these symptoms can improve both maternal and neonatal outcomes. In countries like India, where obstetric complications are frequent, integrating psychological screening into routine care is essential. Identifying antenatal anxiety and depression early allows for a multidisciplinary approach. This approach involves both obstetricians and mental health professionals working together. Ultimately, addressing these mental health needs ensures a more comprehensive care plan. This holistic care plan supports vulnerable mothers throughout their entire perinatal journey.
These conditions create significant stress due to the risk of hemorrhage and emergency surgery. This uncertainty often leads to clinical anxiety during pregnancy and increases the risk of depression after childbirth.
Healthcare providers should ideally screen women at the time of a high-risk diagnosis. They should also continue monitoring through the third trimester and the first year postpartum using tools like the EPDS.
Research indicates a moderate and significant positive correlation between the two. High levels of anxiety during pregnancy often persist and evolve into depressive symptoms after delivery.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Duygulu Bulan D et al. Antenatal anxiety and postpartum depressive symptoms in pregnancies complicated by placenta previa and placenta accreta spectrum. BMC Pregnancy Childbirth. 2026 Feb 09. doi: 10.1186/s12884-026-08790-2. PMID: 41663971.
Çalışkan-Şenay Z et al. Placenta Previa is Associated with Maternal Psychological Distress: A Mediation Analysis of Depression, Anxiety, and Post-Traumatic Stress Symptoms. Psychol Res Behav Manag. 2025 Dec 06;18:123-134.
Upadhyay et al. Perinatal depression in India: A narrative review of prevalence, risk factors, and healthcare provider awareness. J Family Med Prim Care. 2025;14(1):15-22.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A cross-sectional study reveals a strong link between high-risk pregnancies, such as placenta previa, and elevated risks of antenatal anxiety and depression...
8 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today